tiprankstipranks
Satellos Bioscience (TSE:MSCL)
TSX:MSCL
Canadian Market
MSCL
Satellos Bioscience
RESEARCH TOOLSreports

Satellos Bioscience (MSCL) Income Statement

35 Followers

Satellos Bioscience Income Statement

Last quarter (Q4 2025), Satellos Bioscience's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Satellos Bioscience's net income was C$-7.42M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -5.09KC$ -20.00KC$ -8.82MC$ -3.73MC$ -119.92K
Operating Expenses
C$ 26.92MC$ 27.79MC$ 15.46MC$ 8.43MC$ 4.70M
Depreciation and Amortization
C$ 5.09KC$ 20.00KC$ 7.00KC$ 337.00KC$ 165.69K
EBITDA
C$ -26.92MC$ -28.08MC$ -15.71MC$ -8.09MC$ -4.60M
Operating Income
C$ -26.92MC$ -27.81MC$ -15.46MC$ -8.43MC$ -4.74M
Other Income/Expenses
C$ 1.79MC$ -291.00KC$ -426.00KC$ -2.89MC$ -8.86M
Pretax Income
C$ -25.13MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Net Income
C$ -25.31MC$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51M
Per Share Metrics
Basic EPS
C$ -1.73C$ -2.88C$ -2.16C$ -3.84C$ -7.68
Diluted EPS
C$ -1.73C$ -2.88C$ -2.16C$ -3.84C$ -7.68
Weighted Average Shares Outstanding
 14.60M 9.56M 7.20M 2.97M 2.01M
Weighted Average Shares Outstanding (Diluted)
 14.60M 9.56M 7.20M 2.97M 2.01M
Currency in CAD

Satellos Bioscience Earnings and Revenue History